Should I buy or sell Healthcare Global Enterprises?

The average broker rating on Healthcare Global Enterprises is Buy. The breakup of analyst rating is given below - 0.00 analysts have given a strong sell rating 0.00 analysts have given a sell rating 1 analysts have given a hold rating 2 analysts have given a buy rating 1 analysts have given a strong buy rating

Is Healthcare Global Enterprises a good stock to invest in?

Healthcare Global Enterprises can be analyzed on the following key metrics - TTM P/E: 116.76 Sector P/E: 23.64 Dividend Yield: 0% D/E ratio: -

Healthcare Global Enterprises Share Price

Sector: Healthcare Facilities

Powered by

577.05 +27.55 (5.01%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 563.00

Today’s High 579.20

52 Week Low 310.10

52 Week High 606.15

Key Metrics

Market Cap (In Cr) 7950.91
Beta 0.49
Div. Yield (%) 0
P/B 9.28
TTM P/E 116.76
Peg Ratio -
Sector P/E 23.64
Open Price 565.75
Prev Close 549.5

View All Metrics

Healthcare Global Enterprises Analysis

Price Analysis

1 Week

-4.05%
3 Months

4.94%
6 Month

17.69%
YTD

12.5%
1 Year

52.33%

Risk Meter

37% Low risk
37% Moderate risk
37% Balanced Risk
37% High risk
37% Extreme risk

Recos

Strong Sell
Sell
Hold
Buy
Strong Buy

Analysts' Views

Ratings
Current
1 W Ago
1 M Ago
3 M Ago

Strong Buy
1
1
1
1

Buy
2
2
2
4

Hold
1
1
1
0.00

Sell
0.00
0.00
0.00
0.00

Strong Sell
0.00
0.00
0.00
0.00

Total
4
4
4
5

Healthcare Global Enterprises News

Stock market strategy: Sumeet Bagadia, Executive Director at Choice Broking, believes that the Indian stock market sentiment is range-bound as the Nifty 50 index is in 24,050 to 24,350 range. (MINT)

Premium

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy

1 min read . 02 May 2025

Stock market next week: Sumeet Bagadia, Executive Director at Choice Broking, believes that the Indian stock market sentiment has turned positive as the Nifty 50 index decisively broken above the 50-DEMA hurdle placed at 23,000. (MINT)

Premium

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy

1 min read . 16 Apr 2025

Technical Picks: Vinay Rajani of HDFC Securities recommends these three stocks in the near term - HealthCare Global Enterprises Ltd, Aadhar Housing Finance Ltd, and Union Bank of India.

Premium

Vinay Rajani of HDFC Sec suggests these 3 stocks to buy in the near-term

3 min read . 03 Apr 2025

Technical Picks: Vinay Rajani of HDFC Securities recommends these two stocks in the near term - Healthcare Global Enterprises Ltd, HBL Engineering Ltd, and Johnson Controls-Hitachi Air Conditioning India Ltd.

Premium

Vinay Rajani of HDFC Sec suggests these 3 stocks to buy in the near-term

3 min read . 24 Mar 2025

View More News

Healthcare Global Enterprises Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
1907.87

Selling/ General/ Admin Expenses Total
682.6

Depreciation/ Amortization
174.36

Other Operating Expenses Total
9.17

Total Operating Expense
1749.45

Operating Income
158.42

Net Income Before Taxes
67.73

Net Income
48.16

Diluted Normalized EPS
3.26

Period
2023

Total Revenue
1691.41

Selling/ General/ Admin Expenses Total
605.86

Depreciation/ Amortization
163.47

Other Operating Expenses Total
8.4

Total Operating Expense
1557.52

Operating Income
133.89

Net Income Before Taxes
44.88

Net Income
29.35

Diluted Normalized EPS
2.14

Period
2022

Total Revenue
1394.78

Selling/ General/ Admin Expenses Total
498.86

Depreciation/ Amortization
158.28

Other Operating Expenses Total
5.64

Total Operating Expense
1222.85

Operating Income
171.93

Net Income Before Taxes
87.77

Net Income
53.73

Diluted Normalized EPS
-0.54

Period
2021

Total Revenue
1009.19

Selling/ General/ Admin Expenses Total
415.83

Depreciation/ Amortization
159.22

Other Operating Expenses Total
4.86

Total Operating Expense
1139.47

Operating Income
-130.28

Net Income Before Taxes
-228.66

Net Income
-193.46

Diluted Normalized EPS
-11.68

Period
2020

Total Revenue
1092.34

Selling/ General/ Admin Expenses Total
428.7

Depreciation/ Amortization
148.45

Other Operating Expenses Total
4.98

Total Operating Expense
1071.9

Operating Income
20.44

Net Income Before Taxes
-119.26

Net Income
-106.7

Diluted Normalized EPS
-12.05

Period
2019

Total Revenue
976.03

Selling/ General/ Admin Expenses Total
414.67

Depreciation/ Amortization
85.09

Other Operating Expenses Total
5.65

Total Operating Expense
938.48

Operating Income
37.54

Net Income Before Taxes
-33.38

Net Income
-24.8

Diluted Normalized EPS
-2.81

Period
2018

Total Revenue
830.69

Selling/ General/ Admin Expenses Total
340.97

Depreciation/ Amortization
71.46

Other Operating Expenses Total
5.65

Total Operating Expense
772.52

Operating Income
58.17

Net Income Before Taxes
27.18

Net Income
20.52

Diluted Normalized EPS
1.61

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Healthcare Global Enterprises Technical

Moving Average SMA

5 Day563.05
10 Day561.02
20 Day563.5

50 Day533.25
100 Day517.28
300 Day468.34

Healthcare Global Enterprises Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Vijaya Diagnostic Centre
992.1
-1.75
-0.18
1276.75
654.75
10161.59

Metropolis Healthcare
1712.2
45.05
2.7
2306.85
1383.7
8795.92

Healthcare Global Enterprises
577.05
27.55
5.01
606.15
310.1
7950.91

Kovai Medical Cente And Hospital
5582.6
-16.45
-0.29
6400
3750
6172.63

Thyrocare Technologies
958
18.35
1.95
1053.05
570.75
5076.77

Healthcare Global Enterprises Shareholding

Shareholding Pattern

*Promoter pledging: 3.56%

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

14-Feb-25
Quarterly Results & Others

13-Feb-25
Quarterly Results & Others

09-Nov-24
Quarterly Results

08-Aug-24
Quarterly Results

29-May-24
Audited Results & ESOP

08-Feb-24
Quarterly Results

09-Nov-23
Quarterly Results

10-Aug-23
Quarterly Results & ESOP

25-May-23
Audited Results

09-Feb-23
Quarterly Results

Meeting Date
Announced on
Purpose

29-Apr-25
28-Mar-25
POM

25-Sept-24
08-Aug-24
AGM

10-Sept-24
12-Aug-24
POM

30-Jan-24
29-Dec-23
POM

20-Sept-23
10-Aug-23
AGM

27-Jun-23
29-May-23
POM

08-May-22
06-Apr-22
POM

25-May-21
26-Apr-21
POM

View All

Company Profile

ABOUT Healthcare Global Enterprises

Industry Healthcare Facilities
ISIN INE075I01017
BSE Code 539787
NSE Code HCG

HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company is a provider of specialty healthcare focused on cancer and fertility. The Company operates cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company also provide fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology focused approach to diagnosis and treatment. The Triesta brand, it offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company also operates comprehensive cancer care center in Indore, Madhya Pradesh. The Company is also engaged in radiation business in Indore, Madhya Pradesh.

MANAGEMENT

Basavalinga Ajaikumar Executive Chairman of the Board
Meghraj Gore Chief Executive Officer
Ruby Ritolia Chief Financial Officer
Sunu Manuel Compliance Officer, Company Secretary
Anjali Rossi Executive Director - Strategy

HEALTHCARE GLOBAL ENTERPRISES SUMMARY

Healthcare Global Enterprises is trading 5.01% upper at Rs 577.05 as compared to its last closing price. Healthcare Global Enterprises has been trading in the price range of 579.20 & 563.00. Healthcare Global Enterprises has given 12.5% in this year & -4.05% in the last 5 days.

Healthcare Global Enterprises has TTM P/E ratio 116.76 as compared to the sector P/E of 23.64. There are 4 analysts who have initiated coverage on Healthcare Global Enterprises. There are 1 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

The company posted a net profit of 6.98 Crores in its last quarter.

Listed peers of Healthcare Global Enterprises include Vijaya Diagnostic Centre (-0.18%), Metropolis Healthcare (2.7%), Healthcare Global Enterprises (5.01%) etc.

Healthcare Global Enterprises has a 71.22% promoter holding & 28.78% public holding.

FAQs about Healthcare Global Enterprises

Healthcare Global Enterprises is trading at 577.05 as on 12 May, 2025 3:58:18 PM. This is 5.01% upper as compared to its previous closing price of 549.5

The market capitalization of Healthcare Global Enterprises is 7950.91 Cr as on 12 May, 2025 3:58:18 PM.

The average broker rating on Healthcare Global Enterprises is Buy. The breakup of analyst rating is given below -

0.00 analysts have given a strong sell rating
0.00 analysts have given a sell rating
1 analysts have given a hold rating
2 analysts have given a buy rating
1 analysts have given a strong buy rating

The 52 wk high for Healthcare Global Enterprises is 606.15 whereas the 52 wk low is 310.10

Healthcare Global Enterprises can be analyzed on the following key metrics -

TTM P/E: 116.76
Sector P/E: 23.64
Dividend Yield: 0%
D/E ratio: -

Healthcare Global Enterprises reported a net profit of 48.16 Cr in 2024.

Healthcare Global Enterprises Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Healthcare Global Enterprises Share Price

Price Range

Price Range

Key Metrics

Healthcare Global Enterprises Analysis

Healthcare Global Enterprises News

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy

Vinay Rajani of HDFC Sec suggests these 3 stocks to buy in the near-term

Vinay Rajani of HDFC Sec suggests these 3 stocks to buy in the near-term

Healthcare Global Enterprises Financials

Forecast

Forecast

Forecast

Healthcare Global Enterprises Technical

Healthcare Global Enterprises Peers

Healthcare Global Enterprises Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Healthcare Global Enterprises

MANAGEMENT

HEALTHCARE GLOBAL ENTERPRISES SUMMARY

FAQs about Healthcare Global Enterprises

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue